Casualty Medical Systems Incorporated (NASDAQ:CASM) Just Reported Decreased Shorts

January 14, 2018 - By Ellis Scott

 Casualty Medical Systems Incorporated (NASDAQ:CASM) Just Reported Decreased Shorts

Investors sentiment decreased to 0.83 in 2017 Q3. Its down 0.37, from 1.2 in 2017Q2. It worsened, as 2 investors sold CAS Medical Systems, Inc. shares while 4 reduced holdings. 2 funds opened positions while 3 raised stakes. 6.37 million shares or 4.99% more from 6.06 million shares in 2017Q2 were reported.
Royal Comml Bank Of Canada holds 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM) for 20 shares. 20,000 were reported by Rmb Capital Limited Company. California Employees Retirement has invested 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). Manatuck Hill Prtn Limited Company owns 50,000 shares or 0.02% of their US portfolio. Acuta Cap Ptnrs Lc owns 5.09 million shares for 0.84% of their portfolio. Moreover, Td Capital Limited Company has 0.01% invested in CAS Medical Systems, Inc. (NASDAQ:CASM). 11,354 are owned by Blackrock. Wells Fargo Mn accumulated 227 shares. 1492 Capital Ltd Com owns 42,346 shares. Vanguard invested in 0% or 531,881 shares. Guggenheim Capital Ltd Com reported 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). Northern Tru Corporation holds 25,101 shares. Renaissance Techs Llc holds 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM) for 281,800 shares. Hightower Advsr Llc accumulated 245,489 shares. Morgan Stanley, a New York-based fund reported 3,277 shares.

The stock of Casualty Medical Systems Incorporated (NASDAQ:CASM) registered a decrease of 3.78% in short interest. CASM’s total short interest was 249,700 shares in January as published by FINRA. Its down 3.78% from 259,500 shares, reported previously. With 58,900 shares average volume, it will take short sellers 4 days to cover their CASM’s short positions. The short interest to Casualty Medical Systems Incorporated’s float is 1.27%.

The stock decreased 4.67% or $0.05 during the last trading session, reaching $1.02. About 31,319 shares traded. CAS Medical Systems, Inc. (NASDAQ:CASM) has declined 47.56% since January 14, 2017 and is downtrending. It has underperformed by 64.26% the S&P500.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $27.88 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

More recent CAS Medical Systems, Inc. (NASDAQ:CASM) news were published by: Seekingalpha.com which released: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2017 Results – Earnings Call …” on May 03, 2017. Also Seekingalpha.com published the news titled: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q3 2017 Results – Earnings Call …” on November 12, 2017. Globenewswire.com‘s news article titled: “CASMED Names Kimberly Strusky Executive Vice President of US Sales” with publication date: October 05, 2015 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.